uniQure gains FDA Priority Review for Huntington's disease gene therapy

The FDA accepts uniQure's Huntington's gene therapy ifezuntirgene inilparvovec filing with Priority Review. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real